David Langton

Icatibant, a New Bradykinin-Receptor Antagonist, in Hereditary Angioedema

Marco Cicardi, Aleena Banerji, Francisco Bracho et al. · New England Journal of Medicine · 2010 · 554 citations · Full text

Medicine, Pharmacology, Pharmacotherapy +4

Long-term safety and efficacy of benralizumab in patients with severe, uncontrolled asthma: 1-year results from the BORA phase 3 extension trial

William W. Busse, Eugene R. Bleecker, J Mark FitzGerald et al. · The Lancet Respiratory Medicine · 2018 · 311 citations

Pharmacy, Pharmacology, Pharmacotherapy +6

The Melbourne epidemic thunderstorm asthma event 2016: an investigation of environmental triggers, effect on health services, and patient risk factors

Francis Thien, Paul J. Beggs, Danny Csutoros et al. · The Lancet Planetary Health · 2018 · 269 citations · Full text

Public Health, Emergency Medicine, Preventive Medicine +17

Therapeutic Efficacy of Granulocyte-Macrophage Colony-Stimulating Factor in Patients with Idiopathic Acquired Alveolar Proteinosis

John F. Seymour, Jeffrey Presneill, Otto D. Schoch et al. · American Journal of Respiratory and Critical Care Medicine · 2001 · 247 citations

Medicine, Immunology, Pharmacotherapy +15

Mepolizumab effectiveness and identification of super-responders in severe asthma

David Langton, Constance H. Katelaris, Sean Stevens et al. · European Respiratory Journal · 2020 · 193 citations · Full text

Life Sciences, Internal Medicine, Pharmacotherapy +16